The U.S. government, Eli Lilly and Novo Nordisk announced an agreement to lower the price of their GLP-1 weight-loss drug, with the two companies setting the price at $245 per month.
2025-11-07
The U.S. government, Eli Lilly and Novo Nordisk announced an agreement to lower the price of their GLP-1 weight-loss drug, with the two companies setting the price at $245 per month.